# NCT02357992 (NCT02357992)

> Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02357992
- Phase: NA
- Status: COMPLETED
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Lung Cancer
- Interventions: Stereotactic Body Radiotherapy (SABR)
- Enrollment: 122
- Primary outcome: Number of Participants With Overall Survival (OS) at 3 Years

## Indexed commentary on NCT02357992 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 4 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct02357992